The treatment of intragastric curcumin to AD model, lowered the severity of the disease by inhibiting the expression of BACE1. It also reduce the degeneration of synapse and enhance the spatial learning and memory pattern (Zheng et al., 2017). This evidence concerns the gene BACE1 and Alzheimer disease.